Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription Articles published in Allergy Asthma Proc Retrieve available abstracts of 169 articles: HTML format

Single Articles

July 2026
1. HISMIOGULLARI A, Sancakli O, Ocak M, Gunder S, et al
   Key factors in the diagnosis of sesame allergy in children.
   Allergy Asthma Proc. 2026;47:274-281.
   PubMed     Abstract available
   
   
   
2. ACIKALIN B, Ocak M, Sekerel BE
   Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.
   Allergy Asthma Proc. 2026;47:e50-e56.
   PubMed     Abstract available
   
   
   
3. ASLAN SAVAS S, Colkesen F, Gerek ME, Ergun UY, et al
   Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.
   Allergy Asthma Proc. 2026;47:282-290.
   PubMed     Abstract available
   
   
   
4. HAMID N, Merheb D, Love M, Gierer S, et al
   The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.
   Allergy Asthma Proc. 2026;47:304-308.
   PubMed     Abstract available
   
   
   
5. LIU L, Bai Y, Huang Y, Chen J, et al
   The impact of dietary patterns on the risk of asthma in children.
   Allergy Asthma Proc. 2026;47:e65-e72.
   PubMed     Abstract available
   
   
   
6. PLATTS-MILLS TAE, Dunaway CA, Gangwar RS, Workman LJ, et al
   The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.
   Allergy Asthma Proc. 2026;47:237-246.
   PubMed     Abstract available
   
   
   
7. DASH M, Ayub A, Vasudevan B, Sood A, et al
   Correlation of disease activity (Urticaria Activity Score over 7 Days) and quality of life (Chronic Urticaria Quality of Life Questionnaire) in patients with chronic spontaneous urticaria: A prospective observational study.
   Allergy Asthma Proc. 2026;47:e57-e64.
   PubMed     Abstract available
   
   
   
8. LIU EY, Zhang C, Ray T, Nadeau KC, et al
   Patterns of epinephrine prescribing at discharge and length of stay for adult anaphylaxis in U.S. emergency departments.
   Allergy Asthma Proc. 2026;47:264-273.
   PubMed     Abstract available
   
   
   
9. BELLANTI JA, Settipane RA
   Food allergy, biologic therapies, and diagnostic precision: Expanding frontiers in allergy and immunology.
   Allergy Asthma Proc. 2026;47:233-236.
   PubMed    
   
   
   
10. ESTEBAN CA, Cushman GK, Chandra S, Scarpaci MM, et al
    Social context factors and disparities in emergency department use in pediatric food allergy.
    Allergy Asthma Proc. 2026;47:253-263.
    PubMed     Abstract available
    
    
    
11. SCHMALZRIED S, Beckett RD, Davis H, Carreon G, et al
    Icatibant for acute hereditary angioedema attacks in pediatric patients: A systematized review.
    Allergy Asthma Proc. 2026;47:247-252.
    PubMed     Abstract available
    
    
    
12. GALATA Z, Limoncu O, Tunakan Dalgic C, Gumusburun R, et al
    Local anesthetic hypersensitivity: Frequently suspected, rarely proven: A retrospective study of 101 patients.
    Allergy Asthma Proc. 2026;47:297-303.
    PubMed     Abstract available
    
    
    May 2026
13. HUANG J, Kothari M, Revan R, Poowuttikul P, et al
    Inhaler recognition as a marker for adherence in pediatric patients with asthma.
    Allergy Asthma Proc. 2026;47:184-189.
    PubMed     Abstract available
    
    
    
14. YAN QL, Zhang LY, Niu WS, Shi JJ, et al
    Follow-up after discontinuation of omalizumab in patients with moderate-to-severe asthma: A systematic review.
    Allergy Asthma Proc. 2026;47:e24-e35.
    PubMed     Abstract available
    
    
    
15. SMILEY K, Galli L, Grippen Goddard A, Moore L, et al
    Clinical characteristics, type 2 comorbidities, and treatment responses in pediatric and adult chronic spontaneous urticaria: A multicenter retrospective cohort study.
    Allergy Asthma Proc. 2026;47:190-195.
    PubMed     Abstract available
    
    
    
16. KAYIKCI H, Damadoglu E, Cihanbeylerden M, Tuccar C, et al
    Clinical outcomes and risk factors associated with breakthrough reactions in chemotherapy desensitization.
    Allergy Asthma Proc. 2026;47:216-224.
    PubMed     Abstract available
    
    
    
17. ZHENG K, Zhao Y, Li J, Chen X, et al
    Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts.
    Allergy Asthma Proc. 2026;47:e36-e47.
    PubMed     Abstract available
    
    
    
18. MAGEN E, Magen I, Merzon E, Rahamim E, et al
    Comorbidity burden in patients with anaphylaxis: A 25-year nationwide population-based matched case-control study.
    Allergy Asthma Proc. 2026;47:196-206.
    PubMed     Abstract available
    
    
    
19. HORN SR, Ghaffari G, Al-Shaikhly T
    Should we follow the penicillin allergy label trail in approaching patients with a sulfonamide allergy label?
    Allergy Asthma Proc. 2026;47:177-183.
    PubMed     Abstract available
    
    
    
20. PANCHOLY N, Ghaffari G
    Treatment of eosinophilic esophagitis with immune modulating agents.
    Allergy Asthma Proc. 2026;47:170-176.
    PubMed     Abstract available
    
    
    
21. BUCHHEIT KM
    The medical management of chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory in the biologic age.
    Allergy Asthma Proc. 2026;47:162-169.
    PubMed     Abstract available
    
    
    
22. 
    Abstracts presented at the Western Society of Allergy, Asthma & Immunology, February 1-5, 2026, Wailea, Hawaii.
    Allergy Asthma Proc. 2026;47:230.
    PubMed    
    
    
    March 2026
23. GEYIK C, Cansever M, Bektas F, Dorterler K, et al
    Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze.
    Allergy Asthma Proc. 2026;47:124-132.
    PubMed     Abstract available
    
    
    
24. KOCATEPE G, Uygun DFK, Ture S, Velipasaoglu S, et al
    Cow's milk protein allergy: A risk factor for infections in infants?
    Allergy Asthma Proc. 2026;47:e17-e23.
    PubMed     Abstract available
    
    
    
25. GRIFFIN S, Fishbein J, Wetzel T, Puglisi S, et al
    Hypogammaglobulinemia during infancy and atopic dermatitis.
    Allergy Asthma Proc. 2026;47:133-139.
    PubMed     Abstract available
    
    
    
26. LEDFORD DK
    What to do when your adult patient with severe asthma does not respond to a biologic.
    Allergy Asthma Proc. 2026;47:78-84.
    PubMed     Abstract available
    
    
    
27. BELLANTI JA, Settipane RA
    From molecular pathways to meaningful patient management: Navigating complexity in allergy and immunology.
    Allergy Asthma Proc. 2026;47:75-77.
    PubMed    
    
    
    
28. KORKMAZ P, Toprak ID, Demir S, Yegit OO, et al
    Comprehensive assessment of allergic manifestations including drug hypersensitivity in adult patients with inborn errors of immunity.
    Allergy Asthma Proc. 2026;47:140-148.
    PubMed     Abstract available
    
    
    
29. RAY K, Al-Zubaidi K, Seward S, Liegl M, et al
    Breaking barriers: A communication bundle for penicillin allergy label removal.
    Allergy Asthma Proc. 2026;47:120-123.
    PubMed     Abstract available
    
    
    
30. CHASE NM
    Vaccinating patients on biologics for atopic disease: Clinical considerations and evidence-based recommendations.
    Allergy Asthma Proc. 2026;47:85-91.
    PubMed     Abstract available
    
    
    
31. DOLU KO, Unay IF, Tepe Y, Baser Sinoplu ZE, et al
    Mosquito bite hypersensitivity in children: Clinical features outweigh specific IgE in diagnosis.
    Allergy Asthma Proc. 2026;47:112-119.
    PubMed     Abstract available
    
    
    
32. DAVIS-LORTON M, Soteres D, Lumry WR, Hall J, et al
    Real-world quality of life in patients with hereditary angioedema receiving lanadelumab or other long-term prophylaxis.
    Allergy Asthma Proc. 2026;47:102-111.
    PubMed     Abstract available
    
    
    
33. BUSSE P, Wilson K, Farkas H, Fishel S, et al
    Rethinking the management of hereditary angioedema.
    Allergy Asthma Proc. 2026;47:92-101.
    PubMed     Abstract available
    
    
    January 2026
34. TACHDJIAN R, Chase N, Burnette A, Kaufman D, et al
    Incorrect perceptions of first-line treatment of severe allergic reactions with over-the-counter products and how the epinephrine drug delivery system impacts behavior.
    Allergy Asthma Proc. 2026;47:40-46.
    PubMed     Abstract available
    
    
    
35. HAKVERDI O, Ocak M, Sahiner UM, Soyer O, et al
    House dust allergens of children with newly diagnosed hazelnut or sesame allergy.
    Allergy Asthma Proc. 2026;47:47-54.
    PubMed     Abstract available
    
    
    
36. GARD CN, Blase J, Speck A
    An infant with chronic relapsing urticaria.
    Allergy Asthma Proc. 2026;47:70-73.
    PubMed     Abstract available
    
    
    
37. QI H, Jiao N, Qi Y, Sun Y, et al
    Global, regional, and national burden of asthma and risk factors from 1990 to 2021: Global Burden of Disease study 2021.
    Allergy Asthma Proc. 2026;47:e4-e16.
    PubMed     Abstract available
    
    
    
38. PATIN E, Murase EM, Kourosh AS, Murase JE, et al
    Unmasking multifactorial dermatitis: The case for comprehensive diagnostic guidelines in adult atopic dermatitis.
    Allergy Asthma Proc. 2026;47:12-16.
    PubMed     Abstract available
    
    
    
39. BELLANTI JA, Settipane RA
    Across the arc of allergy: From maternal immune tolerance to food sensitization pathways and lifesaving anaphylaxis care.
    Allergy Asthma Proc. 2026;47:1-4.
    PubMed    
    
    
    
40. HABER C, Al-Shaikhly T, Jhaveri P
    Risk of developing eosinophilic esophagitis with preexisting asthma, allergic rhinitis, atopic dermatitis, or food allergy.
    Allergy Asthma Proc. 2026;47:55-60.
    PubMed     Abstract available
    
    
    
41. KOC YILDIRIM S, Erbagci E, Demirel Ogut N, Unal S, et al
    Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal.
    Allergy Asthma Proc. 2026;47:32-39.
    PubMed     Abstract available
    
    
    
42. O'MARA M, Bishop R, Aguilar N, Navalpakam A, et al
    Navigating asthma in pregnancy: Immunologic changes, barriers, and disparities in management.
    Allergy Asthma Proc. 2026;47:5-11.
    PubMed     Abstract available
    
    
    
43. SHUKLA P, Chiu A, Elms N, MacGinnitie A, et al
    Optimizing diagnostic approaches for allergic bronchopulmonary aspergillosis: Comparative analysis of IgG/IgE ELISA and serum precipitins assays.
    Allergy Asthma Proc. 2026;47:25-31.
    PubMed     Abstract available
    
    
    
44. ALIX V, Abdul Raheem J, Gabreski L, Adams K, et al
    Winged hymenoptera: Discordance between In vitro and In vivo sensitization.
    Allergy Asthma Proc. 2026;47:17-24.
    PubMed     Abstract available
    
    
    
45. ISKENDER N, Ozanli I, Uluc NN, Ipekci B, et al
    Is atopic comorbidity increased in proctocolitis?
    Allergy Asthma Proc. 2026;47:61-69.
    PubMed     Abstract available
    
    
    September 2025
46. GOLDEN DBK
    Update in stinging insect hypersensitivity.
    Allergy Asthma Proc. 2025;46:382-387.
    PubMed     Abstract available
    
    
    
47. OZANLI I, Uluc NN, Iskender N, Akin TY, et al
    Food allergy concurrent with atopic dermatitis: Correlation with age of onset and severity.
    Allergy Asthma Proc. 2025;46:e137-e143.
    PubMed     Abstract available
    
    
    
48. TELLI O, Aksu K, Akkale O, Tuglu HC, et al
    The impact of aeroallergen sensitization on bronchial hyperreactivity in adults.
    Allergy Asthma Proc. 2025;46:e151-e156.
    PubMed     Abstract available
    
    
    
49. TEKCAN D, Guler T, Comert M, Artac H, et al
    Comparison of negative predictive values of single- and two-day provocation tests with suspected nonsteroidal anti-inflammatory drug and paracetamol allergy in children.
    Allergy Asthma Proc. 2025;46:e166-e171.
    PubMed     Abstract available
    
    
    
50. KARATAS P, Gulec Koksal Z, Uysal P
    Egg allergy in children: Patterns of consumption of homemade fermented milk products by mothers during pregnancy.
    Allergy Asthma Proc. 2025;46:e144-e150.
    PubMed     Abstract available
    
    
    
51. LEVY DS, Nagase FI, Cheung A, Rodeberg DA, et al
    Quality of life and burden of disease in patients with hereditary angioedema and their caregivers.
    Allergy Asthma Proc. 2025;46:398-405.
    PubMed     Abstract available
    
    
    
52. WALLACE DV
    Pediatric allergen immunotherapy in the United States: Current practice, safety, and unmet needs for long-term and preventive outcomes.
    Allergy Asthma Proc. 2025;46:362-381.
    PubMed     Abstract available
    
    
    
53. ZHANG N, Xie C, Chen J, Chen H, et al
    The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults.
    Allergy Asthma Proc. 2025;46:e157-e165.
    PubMed     Abstract available
    
    
    
54. BELLANTI JA
    Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?
    Allergy Asthma Proc. 2025;46:354-361.
    PubMed     Abstract available
    
    
    
55. BELLANTI JA, Settipane RA
    Artificial intelligence and allergy: Shaping the future of diagnosis and therapy.
    Allergy Asthma Proc. 2025;46:351-353.
    PubMed    
    
    
    
56. HATCHER VR, Caballero MY, Schuldt MM, Adams KE, et al
    Got milk? Enzyme-linked immunosorbent assay analysis of casein proteins in methylprednisolone.
    Allergy Asthma Proc. 2025;46:431-437.
    PubMed     Abstract available
    
    
    
57. YILMAZ D, Yilmaz Topal O, Sengul Emeksiz Z, Dibek Misirlioglu E, et al
    Evaluation of diagnostic tests for suspected hypersensitivity reactions to proton pump inhibitors in children.
    Allergy Asthma Proc. 2025;46:471-477.
    PubMed     Abstract available
    
    
    
58. DAVIS J, Ward ER, Huang X, Staggers KA, et al
    Food allergy referral patterns from 2013-2015 to 2016-2018 at Texas Children's Hospital.
    Allergy Asthma Proc. 2025;46:e172-e175.
    PubMed     Abstract available
    
    
    
59. SELNER GE, Nicolaides RE, Chow TG
    Caregiver perceptions of beta-lactam allergy testing for serum sickness-like reactions.
    Allergy Asthma Proc. 2025;46:478-483.
    PubMed     Abstract available
    
    
    
60. GENIS C, Torun Ozel C, Selmanoglu A, Sengul Emeksiz Z, et al
    Pediatric ondansetron hypersensitivity: Clinical features and a preliminary diagnostic approach.
    Allergy Asthma Proc. 2025;46:e183-e190.
    PubMed     Abstract available
    
    
    
61. GUPTA RS, Yang MS
    Managing food allergies in each stage of life.
    Allergy Asthma Proc. 2025;46:444-449.
    PubMed     Abstract available
    
    
    
62. LARENAS-LINNEMANN D, Mosges R
    In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites.
    Allergy Asthma Proc. 2025;46:e176-e182.
    PubMed     Abstract available
    
    
    
63. FLUGT A, Rasmussen HM, Agertoft L, Moller S, et al
    Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low.
    Allergy Asthma Proc. 2025;46:506-511.
    PubMed     Abstract available
    
    
    
64. MILUSKI T, Bhattarai B, Al-Shaikhly T
    Anaphylaxis related to fluoroquinolones: A disproportionality analysis of the FDA Adverse Event Reporting System data base.
    Allergy Asthma Proc. 2025;46:484-488.
    PubMed     Abstract available
    
    
    
65. WHALLEY D, Balp MM, Naujoks C, Gardner DD, et al
    Adaptation of the urticaria patient daily diary for caregiver completion in pediatric chronic spontaneous urticaria.
    Allergy Asthma Proc. 2025;46:462-470.
    PubMed     Abstract available
    
    
    
66. LANG DM
    Management of chronic urticaria: Treatment options when omalizumab fails.
    Allergy Asthma Proc. 2025;46:455-461.
    PubMed     Abstract available
    
    
    
67. BERNSTEIN DI
    Aeroallergen immunotherapy update: Developments since the third Practice Parameter.
    Allergy Asthma Proc. 2025;46:450-454.
    PubMed     Abstract available
    
    
    
68. ORAK AKBAY N, Ozdel Ozturk B, Doganci A, Celebi Sozener Z, et al
    The value of skin testing with tumor necrosis factor-inhibitors in patients with local and systemic hypersensitivity reactions.
    Allergy Asthma Proc. 2025;46:489-497.
    PubMed     Abstract available
    
    
    July 2025
69. CAKMAK ME, Oztop N
    Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience.
    Allergy Asthma Proc. 2025;46:323-327.
    PubMed     Abstract available
    
    
    
70. LIU N, Ding Y, Hu C, Luo F, et al
    Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis.
    Allergy Asthma Proc. 2025;46:e125-e136.
    PubMed     Abstract available
    
    
    
71. KNOWLES TR, Nehme KJ, Kim SL, Saltoun CA, et al
    Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics.
    Allergy Asthma Proc. 2025;46:328-334.
    PubMed     Abstract available
    
    
    
72. ARSLAN B, Pacaci Cetin G, Seker S, Bozkurt Yilmaz HE, et al
    Omalizumab home injection versus hospital administration in severe asthma: Impact on asthma control.
    Allergy Asthma Proc. 2025;46:274-279.
    PubMed     Abstract available
    
    
    
73. ONALAN T, Colkesen F, Akkus FA, Gerek ME, et al
    Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making.
    Allergy Asthma Proc. 2025;46:287-295.
    PubMed     Abstract available
    
    
    
74. WATERS CD, Cruzan A, Silge R
    Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization.
    Allergy Asthma Proc. 2025;46:335-338.
    PubMed     Abstract available
    
    
    
75. HORMET IGDE M, Korkmaz P, Toprak ID, Eyice Karabacak D, et al
    Idiopathic mast cell activation syndrome in real-life practice: clinical features and management.
    Allergy Asthma Proc. 2025;46:314-322.
    PubMed     Abstract available
    
    
    
76. AYTEKIN F, Efe O, Beyhan N, Gidik E, et al
    Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis.
    Allergy Asthma Proc. 2025;46:280-286.
    PubMed     Abstract available
    
    
    
77. BURCH MO, Rocha DG, Belleze L, Da Silva MJO, et al
    Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy.
    Allergy Asthma Proc. 2025;46:296-303.
    PubMed     Abstract available
    
    
    
78. 
    Abstracts Presented at the Eastern Allergy Conference May 29-June 1, 2025, Palm Beach, Florida.
    Allergy Asthma Proc. 2025;46:339-348.
    PubMed    
    
    
    June 2025
79. CHEN Z, Lin C, Zhang J
    Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China.
    Allergy Asthma Proc. 2025 Jun 24. doi: 10.2500/aap.2025.46.250040.
    PubMed     Abstract available
    
    
    May 2025
80. LUCCIOLI S, Seabol L
    Anaphylaxis in children: Latest insights.
    Allergy Asthma Proc. 2025;46:168-184.
    PubMed     Abstract available
    
    
    
81. AKTEN HS, Dilek E, Orman M, Mete Gokmen EN, et al
    Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment.
    Allergy Asthma Proc. 2025;46:e71-e81.
    PubMed     Abstract available
    
    
    
82. 
    New England Society of Allergy Spring Meeting Abstracts presented March 28, 2025, Worcester, MA.
    Allergy Asthma Proc. 2025;46:267-268.
    PubMed    
    
    
    
83. YEGIT OO, Gelmez MY, Demir S, Akdeniz N, et al
    Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test.
    Allergy Asthma Proc. 2025;46:247-256.
    PubMed     Abstract available
    
    
    
84. YOUNG MC, Banerji A
    Angioedema without urticaria: Diagnosis and management.
    Allergy Asthma Proc. 2025;46:185-191.
    PubMed     Abstract available
    
    
    
85. YILMAZ TOPAL O, Tekgoz N, Kaplan MM, Yigit M, et al
    Evaluation of the frequency of allergic diseases in pediatric patients with juvenile idiopathic arthritis.
    Allergy Asthma Proc. 2025;46:e110-e116.
    PubMed     Abstract available
    
    
    
86. ZHANG W, Cao L, Sun J, Zhang C, et al
    Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005-2018.
    Allergy Asthma Proc. 2025;46:e82-e90.
    PubMed     Abstract available
    
    
    
87. GUILARTE M, Lumry WR, Magerl M, Martinez Saguer I, et al
    Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema.
    Allergy Asthma Proc. 2025;46:192-199.
    PubMed     Abstract available
    
    
    
88. GUL O, Bayrak Durmaz MS, Yildiz R, Aytekin F, et al
    Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience.
    Allergy Asthma Proc. 2025;46:240-246.
    PubMed     Abstract available
    
    
    
89. SANDERS J, Greenhawt M, Oppenheimer J, Anagnostou A, et al
    Value-based care in allergy-immunology: Beyond the quality-adjusted life year.
    Allergy Asthma Proc. 2025;46:165-167.
    PubMed     Abstract available
    
    
    
90. ZHENG K, Wang X
    Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies.
    Allergy Asthma Proc. 2025;46:e98-e109.
    PubMed     Abstract available
    
    
    
91. BELLANTI JA, Settipane RA
    From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention.
    Allergy Asthma Proc. 2025;46:161-164.
    PubMed    
    
    
    
92. STAUBACH P, Craig TJ, Fukuda T, Aygoren-Pursun E, et al
    Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab.
    Allergy Asthma Proc. 2025;46:200-208.
    PubMed     Abstract available
    
    
    
93. GENIS C, Kuzucu FN, Selmanoglu A, Ipek Demir K, et al
    Antibiotic allergy in children: Can the severity and characteristics of the index reaction predict drug provocation test results?
    Allergy Asthma Proc. 2025;46:227-234.
    PubMed     Abstract available
    
    
    
94. SOCOLOVSKY C, Louisias M, Alsulami S, Petty CR, et al
    Cost-effectiveness of school integrated pest management and air filtration in students with asthma.
    Allergy Asthma Proc. 2025;46:257-266.
    PubMed     Abstract available
    
    
    
95. ZURAW BL, Lopez-Gonzalez L, Manjelievskaia J, Winer I, et al
    Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United States.
    Allergy Asthma Proc. 2025;46:209-217.
    PubMed     Abstract available
    
    
    
96. BRAVERMAN J, Ellis D, Gavata-Steiger S, Dhas AB, et al
    Analyzing social media conversations to gain insights into the experiences of patients with hereditary angioedema.
    Allergy Asthma Proc. 2025;46:218-226.
    PubMed     Abstract available
    
    
    March 2025
97. KE X, Liu S, Wang X, You J, et al
    Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis.
    Allergy Asthma Proc. 2025;46:e43-e60.
    PubMed     Abstract available
    
    
    
98. ONALAN T, Colkesen F, Gerek ME, Akkus FA, et al
    Rapid drug desensitization in seven patients with delayed hypersensitivity reactions to biologics and targeted therapies: Reason, successes, and failures.
    Allergy Asthma Proc. 2025;46:e70-e77.
    PubMed     Abstract available
    
    
    
99. MAGEN E, Merzon E, Green I, Magen I, et al
    Allergic comorbidities in fibromyalgia.
    Allergy Asthma Proc. 2025;46:e33-e42.
    PubMed     Abstract available
    
    
    
100. MONGKONSRITRAGOON W, Varre A, Beydoun S, Revan R, et al
     Factors associated with treatment response in eosinophilic esophagitis patients: Experience from a pediatric tertiary care center.
     Allergy Asthma Proc. 2025;46:135-143.
     PubMed     Abstract available
     
     
     
101. KAYIKCI H, Damadoglu E, Cihanbeylerden M, Tuccar C, et al
     Clinical characteristics and biological treatment responses of patients with late-onset asthma phenotype.
     Allergy Asthma Proc. 2025;46:109-118.
     PubMed     Abstract available
     
     
     
102. WANG M, Gao X, Zhang L
     Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis.
     Allergy Asthma Proc. 2025;46:88-97.
     PubMed     Abstract available
     
     
     
103. CAO X, Zhao G, Peng H, Mi Y, et al
     Association between allergic diseases and hypertension: Co-occurrence pattern analysis.
     Allergy Asthma Proc. 2025;46:e61-e69.
     PubMed     Abstract available
     
     
     
104. ASLAN AF, Demir S, Toprak ID, Korkmaz P, et al
     From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts.
     Allergy Asthma Proc. 2025;46:152-158.
     PubMed     Abstract available
     
     
     
105. BELLANTI JA, Settipane RA
     Type 2 inflammation: A unifying pathway in allergic diseases and a call to action for the Allergist-Immunologist.
     Allergy Asthma Proc. 2025;46:79-81.
     PubMed    
     
     
     
106. AKKUS FA, Colkesen F, Onalan T, Evcen R, et al
     Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma.
     Allergy Asthma Proc. 2025;46:119-125.
     PubMed     Abstract available
     
     
     
107. ENGELHARDT E, Prince BT, Stukus DR, Messeh E, et al
     To test or not to test: Lessons learned from screening infants for peanut allergy.
     Allergy Asthma Proc. 2025;46:144-151.
     PubMed     Abstract available
     
     
     
108. CONWAY AE, Kartha N, Shaker MS, Davis RS, et al
     Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience.
     Allergy Asthma Proc. 2025;46:82-87.
     PubMed     Abstract available
     
     
     January 2025
109. YUSUFOVA N, Gilbert IA, Trudo F, Barlows T, et al
     Evaluation of a disease-state education program in asthma: Application of the Knowledge-to-Action Framework.
     Allergy Asthma Proc. 2025 Jan 27. doi: 10.2500/aap.2025.46.240112.
     PubMed     Abstract available
     
     
     
110. CHRISTIANSEN SC, Zuraw BL
     Idiopathic non-mast cell angioedema: Treatment insights from global experts.
     Allergy Asthma Proc. 2025;46:38-44.
     PubMed     Abstract available
     
     
     
111. GOTOH M, Maekawa Y, Saito S, Kato N, et al
     Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan.
     Allergy Asthma Proc. 2025;46:59-69.
     PubMed     Abstract available
     
     
     
112. CELIK HI, Guvenir FA, Emeksiz ZS, Misirlioglu ED, et al
     Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis.
     Allergy Asthma Proc. 2025;46:e1-e5.
     PubMed     Abstract available
     
     
     
113. JAROENPUNTARUK V, Volcheck GW
     Perioperative anaphylaxis manifesting as cardiac arrest during cardiac surgery.
     Allergy Asthma Proc. 2025;46:70-75.
     PubMed     Abstract available
     
     
     
114. PAPAIOANNOU AI, Kallieri M, Zervas E, Fouka E, et al
     Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study.
     Allergy Asthma Proc. 2025;46:45-51.
     PubMed     Abstract available
     
     
     
115. PETERSEN MM
     Allergen immunotherapy: How to stay current with USP 797 and practice guidelines.
     Allergy Asthma Proc. 2025;46:26-31.
     PubMed     Abstract available
     
     
     
116. GABBAY JM, Fishman MD, Bajaj BVM, Guenther CS, et al
     Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study.
     Allergy Asthma Proc. 2025;46:e6-e12.
     PubMed     Abstract available
     
     
     
117. BOGUNIEWICZ M
     Atopic dermatitis: Best of guidelines and yardstick.
     Allergy Asthma Proc. 2025;46:19-25.
     PubMed     Abstract available
     
     
     
118. LI D, Sorkhabi S, Cruz I, Foley PL, et al
     Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease.
     Allergy Asthma Proc. 2025;46:e13-e23.
     PubMed     Abstract available
     
     
     
119. MARI D, Henson K, Day W, Mcglynn A, et al
     Health disparities investigated in a primary care penicillin allergy removal pathway.
     Allergy Asthma Proc. 2025;46:52-58.
     PubMed     Abstract available
     
     
     
120. LUMRY WR, Grumach AS, Betschel SD, Radojicic C, et al
     Management of hereditary angioedema attacks by patients on long-term prophylaxis versus on-demand therapy only.
     Allergy Asthma Proc. 2025;46:32-37.
     PubMed     Abstract available
     
     
     November 2024
121. HATCHER VR, Adams KE
     Military accession, retention, and deployment: Defining the role of the allergy consultant.
     Allergy Asthma Proc. 2024;45:404-408.
     PubMed     Abstract available
     
     
     
122. EKE GUNGOR H, Turk M, Yucel MB, Koca SB, et al
     Eating increases disease activity in pediatric patients with symptomatic dermographism.
     Allergy Asthma Proc. 2024;45:e65-e71.
     PubMed     Abstract available
     
     
     
123. 
     Abstracts presented at the Eastern Allergy Conference May 30-June 2, 2024, Palm Beach, Florida.
     Allergy Asthma Proc. 2024;45:461-469.
     PubMed    
     
     
     
124. SHAKER MS
     The use of biologics in food allergy management.
     Allergy Asthma Proc. 2024;45:409-413.
     PubMed     Abstract available
     
     
     
125. DOGAN S, Ertugrul A, Ozer M, Severcan EU, et al
     Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity.
     Allergy Asthma Proc. 2024;45:e81-e86.
     PubMed     Abstract available
     
     
     
126. DENG E, Craig TJ, Nguyen DV, Al-Shaikhly T, et al
     COVID-19 and severe cutaneous allergic reactions to sulfonamides.
     Allergy Asthma Proc. 2024;45:e93-e100.
     PubMed     Abstract available
     
     
     
127. MORITZ G, Becker JH, Ankam JV, Arcoleo K, et al
     Considering different Montreal Cognitive Assessment cutoff scores for older adults with asthma.
     Allergy Asthma Proc. 2024;45:e72-e80.
     PubMed     Abstract available
     
     
     
128. ODIN R, Anderson J, Jacobs J, Jones D, et al
     The utility of shared decision making in the management of hereditary angioedema.
     Allergy Asthma Proc. 2024;45:434-437.
     PubMed     Abstract available
     
     
     
129. POLLOCK J, Watson N, Pittman L, Schwartz D, et al
     Ultrafiltered dog allergen skin test compared with acetone precipitated and conventional dog: A retrospective study.
     Allergy Asthma Proc. 2024;45:453-455.
     PubMed     Abstract available
     
     
     
130. HELLU T, Gomez R, Weiss S, Smith D, et al
     Do commercial dog extracts cross-react with Felis domesticus allergen 1.
     Allergy Asthma Proc. 2024;45:447-452.
     PubMed     Abstract available
     
     
     
131. BELLANTI JA, Settipane RA
     Integrating innovation and shared decision-making in allergy and immunology practice.
     Allergy Asthma Proc. 2024;45:395-397.
     PubMed    
     
     
     
132. ZHENG K, Wang X, Tang L, Chen L, et al
     A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children.
     Allergy Asthma Proc. 2024;45:e101-e110.
     PubMed     Abstract available
     
     
     
133. MULLUR J, Lundberg M, Maurer R, Laidlaw TM, et al
     Dupilumab rapidly improves eustachian tube dysfunction and otologic symptoms in aspirin-exacerbated respiratory disease.
     Allergy Asthma Proc. 2024;45:421-425.
     PubMed     Abstract available
     
     
     
134. HUANG YC, Caldarone L, Sherman C, Deutsch R, et al
     The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis.
     Allergy Asthma Proc. 2024;45:438-446.
     PubMed     Abstract available
     
     
     
135. ANDERSON J, Soteres D, Tachdjian R, Mellor J, et al
     Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis.
     Allergy Asthma Proc. 2024;45:426-433.
     PubMed     Abstract available
     
     
     September 2024
136. BELLANTI JA, Settipane RA
     Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT).
     Allergy Asthma Proc. 2024;45:291-293.
     PubMed    
     
     
     July 2024
137. AKTEN HS, Tunakan Dalgc C, Demir M, Okan K, et al
     Early testing and grade of the reaction are affecting factors of skin test positivity in beta-Lactam allergies.
     Allergy Asthma Proc. 2024;45:e23-e30.
     PubMed     Abstract available
     
     
     
138. CAKMAK ME, Bostan OC, Kaya SB, Karakaya G, et al
     Assessment of clinical phenotypic characteristics of patients with angioedema without wheals in a turkish population.
     Allergy Asthma Proc. 2024;45:240-246.
     PubMed     Abstract available
     
     
     
139. SANDOVAL A, Jung Y, Kim I, Sadigh N, et al
     Evaluation of atopic diseases in patients with allergic contact dermatitis.
     Allergy Asthma Proc. 2024;45:262-267.
     PubMed     Abstract available
     
     
     
140. GULTUNA S, Basa Akdogan B, Gonul M, Aydin FN, et al
     Sleep quality in patients with chronic spontaneous urticaria and relation with Orexin-A, leptin, and ghrelin.
     Allergy Asthma Proc. 2024;45:e38-e45.
     PubMed     Abstract available
     
     
     
141. XIE T, Zhong LL
     Association of serum pertussis antibodies with acute asthma attacks in children.
     Allergy Asthma Proc. 2024;45:e54-e61.
     PubMed     Abstract available
     
     
     
142. AYTEKIN GUVENIR F, Sengul Emeksiz Z, Buyuk Yaytokgil S, Toyran M, et al
     Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings.
     Allergy Asthma Proc. 2024;45:e31-e37.
     PubMed     Abstract available
     
     
     
143. KAYIKCI H, Bostan OC, Tuncay G, Cihanbeylerden M, et al
     Efficacy and safety of hymenoptera venom immunotherapy.
     Allergy Asthma Proc. 2024;45:268-275.
     PubMed     Abstract available
     
     
     
144. ANDERSON J, Soteres D, Mellor J, Connolly H, et al
     Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study.
     Allergy Asthma Proc. 2024;45:247-254.
     PubMed     Abstract available
     
     
     
145. KHAN A, Camacho JV, Cummins H, Tahir H, et al
     Not all marketed skin cleansers' pH is optimal for atopic dermatitis.
     Allergy Asthma Proc. 2024;45:284-287.
     PubMed     Abstract available
     
     
     
146. BELLANTI JA, Settipane RA
     Perspectives on allergic diseases: From asthma to food allergy - A continuing challenge for the Allergist-Immunologist.
     Allergy Asthma Proc. 2024;45:215-218.
     PubMed    
     
     
     
147. JIN Z, Wang W, Fineman S, Liu Y, et al
     Leveraging advanced sensors in pollen research.
     Allergy Asthma Proc. 2024;45:e62-e64.
     PubMed    
     
     
     
148. BAKAY OSK, Kacar N, Gul B, Goksin S, et al
     What can be learned from real-world data about chronic spontaneous urticaria?
     Allergy Asthma Proc. 2024;45:255-261.
     PubMed     Abstract available
     
     
     
149. BUYUKTIRYAKI B, Hela F, Ozturk AB, Dursun AB, et al
     Clinical features, severity, and immunological changes during venom immunotherapy in children and adults.
     Allergy Asthma Proc. 2024;45:276-283.
     PubMed     Abstract available
     
     
     
150. BLEECKER E, Blaiss M, Jacob-Nara J, Huynh L, et al
     Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.
     Allergy Asthma Proc. 2024;45:219-231.
     PubMed     Abstract available
     
     
     May 2024
151. STRANZL T, Bernstein DI, Matsuoka T, Durham S, et al
     Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions.
     Allergy Asthma Proc. 2024 May 17. doi: 10.2500/aap.2024.45.240020.
     PubMed     Abstract available
     
     
     
152. GENIS C, Sengul Emeksiz Z, Buyuk Yaylatokgil S, Ginis T, et al
     Successful rapid liposomal amphotericin B desensitization in pediatric case series.
     Allergy Asthma Proc. 2024;45:201-206.
     PubMed     Abstract available
     
     
     
153. BELLANTI JA, Settipane RA
     Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.
     Allergy Asthma Proc. 2024;45:143-146.
     PubMed    
     
     
     
154. MARI DC, Banks TA
     Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy.
     Allergy Asthma Proc. 2024;45:207-210.
     PubMed     Abstract available
     
     
     
155. KATIAL JM, Hoyte FCL, Khatiwada A, Katial RK, et al
     Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis.
     Allergy Asthma Proc. 2024;45:158-165.
     PubMed     Abstract available
     
     
     
156. WANG K, Zhang Y, Wan L, Li J, et al
     Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure.
     Allergy Asthma Proc. 2024;45:173-179.
     PubMed     Abstract available
     
     
     
157. RADOJICIC C, Anderson J
     Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.
     Allergy Asthma Proc. 2024;45:147-157.
     PubMed     Abstract available
     
     
     
158. BRUNETTO S, Gammeri L, Buta F, Gangemi S, et al
     Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts.
     Allergy Asthma Proc. 2024;45:195-200.
     PubMed     Abstract available
     
     
     
159. AYDIN O, Akbay NO, Buyukatalay ZC, Arslan F, et al
     Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease.
     Allergy Asthma Proc. 2024;45:166-172.
     PubMed     Abstract available
     
     
     
160. TALIERCIO MJ, Alnabulsi RK, Uppal PA, Shaw IM, et al
     Metal implant allergy: A retrospective cohort analysis at a university allergy practice.
     Allergy Asthma Proc. 2024;45:186-194.
     PubMed     Abstract available
     
     
     March 2024
161. SHIN S, Jang S, Kim J, Song J, et al
     Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy.
     Allergy Asthma Proc. 2024;45:128-136.
     PubMed     Abstract available
     
     
     
162. BELLANTI JA, Settipane RA
     Allergic diseases in children: A continuing challenge for the Allergist-Immunologist.
     Allergy Asthma Proc. 2024;45:81-83.
     PubMed    
     
     
     
163. BALOH CH, Hsu JT
     Oral immunotherapy with sunflower seed butter and a review of seed allergy.
     Allergy Asthma Proc. 2024;45:137-140.
     PubMed     Abstract available
     
     
     
164. RUDSENSKE NE, Perkins JB
     Assessing severity of COVID-19 and the development of multi system inflammatory syndrome in children (MIS-C) in pediatric patients with atopic disease.
     Allergy Asthma Proc. 2024;45:92-96.
     PubMed     Abstract available
     
     
     
165. NAVALPAKAM A, Thanaputkaiporn N, Aijja C, Mongkonsritragoon W, et al
     Impact of steroids on the immune profiles of children with asthma living in the inner-city.
     Allergy Asthma Proc. 2024;45:100-107.
     PubMed     Abstract available
     
     
     
166. KAZANCIOGLU A, Konuralp I, Sahiner UM, Soyer O, et al
     Understanding of lipid transfer protein sensitization patterns and its clinical significance in children.
     Allergy Asthma Proc. 2024;45:120-127.
     PubMed     Abstract available
     
     
     
167. KELLER L, Perera EK, Bindon B, Khatiwada A, et al
     Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis.
     Allergy Asthma Proc. 2024;45:97-99.
     PubMed     Abstract available
     
     
     
168. PARK M, Yum HY, Bae JM, Lee S, et al
     Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study.
     Allergy Asthma Proc. 2024;45:112-119.
     PubMed     Abstract available
     
     
     
169. BERNSTEIN JA, Wymer LJ, Nye M, Vesper SJ, et al
     The relationship between childhood atopic dermatitis and asthma in an under resourced community.
     Allergy Asthma Proc. 2024;45:108-111.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum